Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2014

Open Access 01-12-2014 | Research article

Mental health in adolescents with Type 1 diabetes: results from a large population-based study

Authors: Børge Sivertsen, Keith J Petrie, Ane Wilhelmsen-Langeland, Mari Hysing

Published in: BMC Endocrine Disorders | Issue 1/2014

Login to get access

Abstract

Background

Diabetes has previously been linked to mental health problems in adolescents, but more recent studies have yielded mixed findings. The aim of the current study was to compare symptoms of mental health problems, sleep and eating disturbances in adolescents with and without Type 1 diabetes in a population based sample.

Methods

Data were taken from the youth@hordaland study, a large population based study in Hordaland County in Norway conducted in 2012. In all, 9883 adolescents aged 16–19 years (53% girls) provided self-reported data on both diabetes and a range of instruments assessing mental health symptoms, including depression, anxiety, obsessive-compulsive behaviours, hyperactivity, impulsivity, inattention, perfectionism, resilience, sleep problems and eating behaviour.

Results

40 adolescents were classified as having Type 1 diabetes (prevalence 0.4%). We found that adolescents with Type 1 diabetes did not differ from their peers on any of the mental health measures.

Conclusions

This is one of the first population-based studies to examine mental health of adolescents with Type 1 diabetes. There was no evidence of increased psychopathology across a wide range of mental health measures. These findings contradict previous studies, and suggest that Type 1 diabetes is not associated with an increased risk of psychosocial problems.
Appendix
Available only for authorised users
Literature
1.
Bernstein CM, Stockwell MS, Gallagher MP, Rosenthal SL, Soren K: Mental health issues in adolescents and young adults with type 1 diabetes: prevalence and impact on glycemic control. Clin Pediatr. 2013, 52 (1): 10-15. 10.1177/0009922812459950.CrossRef
2.
Jacobson AM, Hauser ST, Willett JB, Wolfsdorf JI, Dvorak R, Herman L, de Groot M: Psychological adjustment to IDDM: 10-year follow-up of an onset cohort of child and adolescent patients. Diabetes Care. 1997, 20 (5): 811-818. 10.2337/diacare.20.5.811.CrossRefPubMed
3.
Kovacs M, Obrosky DS, Goldston D, Drash A: Major depressive disorder in youths with IDDM. A controlled prospective study of course and outcome. Diabetes Care. 1997, 20 (1): 45-51. 10.2337/diacare.20.1.45.CrossRefPubMed
4.
Kakleas K, Kandyla B, Karayianni C, Karavanaki K: Psychosocial problems in adolescents with type 1 diabetes mellitus. Diabetes Metab. 2009, 35 (5): 339-350. 10.1016/j.diabet.2009.05.002.CrossRefPubMed
5.
Laffel LM, Connell A, Vangsness L, Goebel-Fabbri A, Mansfield A, Anderson BJ: General quality of life in youth with type 1 diabetes: relationship to patient management and diabetes-specific family conflict. Diabetes Care. 2003, 26 (11): 3067-3073. 10.2337/diacare.26.11.3067.CrossRefPubMed
6.
Frey MA, Guthrie B, Loveland-Cherry C, Park PS, Foster CM: Risky behavior and risk in adolescents with IDDM. J Adolesc Health. 1997, 20 (1): 38-45. 10.1016/S1054-139X(96)00162-0.CrossRefPubMed
7.
Yeshayahu Y, Mahmud FH: Altered sleep patterns in adolescents with type 1 diabetes: implications for insulin regimen. Diabetes Care. 2010, 33 (11): e142-10.2337/dc10-1536.CrossRefPubMed
8.
Reynolds KA, Helgeson VS: Children with diabetes compared to peers: depressed? Distressed? A meta-analytic review. Ann Behav Med. 2011, 42 (1): 29-41. 10.1007/s12160-011-9262-4.CrossRefPubMedPubMedCentral
9.
Lawrence JM, Standiford DA, Loots B, Klingensmith GJ, Williams DE, Ruggiero A, Liese AD, Bell RA, Waitzfelder BE, McKeown RE: Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for diabetes in youth study. Pediatrics. 2006, 117 (4): 1348-1358. 10.1542/peds.2005-1398.CrossRefPubMed
10.
Skrivarhaug T, Kummernes SJ, Drivvoll AK: The Norwegian Childhood Diabetes Registry (NCDR) Annual Report 2012. 2013, Oslo, Norway: Oslo Universitetessykehus
11.
Knight JR, Shrier LA, Bravender TD, Farrell M, Vander Bilt J, Shaffer HJ: A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med. 1999, 153 (6): 591-596.CrossRefPubMed
12.
Thapar A, McGuffin P: Validity of the shortened mood and feelings questionnaire in a community sample of children and adolescents: a preliminary research note. Psychiatry Research. 1998, 81 (2): 259-268. 10.1016/S0165-1781(98)00073-0.CrossRefPubMed
13.
Lundervold AJ, Posserud M, Stormark K, Breivik B, Hysing M: Symptoms of depression as reported by Norwegian adolescents on the short mood and feelings questionnaire. Frontiers in Psychology. 2013, 4: 613-CrossRefPubMedPubMedCentral
14.
Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M: Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc. 1999, 38 (10): 1230-1236. 10.1097/00004583-199910000-00011.CrossRef
15.
Kessler RC, Adler LA, Gruber MJ, Sarawate CA, Spencer T, Van Brunt DL: Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res. 2007, 16 (2): 52-65. 10.1002/mpr.208.CrossRefPubMedPubMedCentral
16.
Adler LA, Shaw DM, Spencer TJ, Newcorn JH, Hammerness P, Sitt DJ, Minerly C, Davidow JV, Faraone SV: Preliminary examination of the reliability and concurrent validity of the attention-deficit/hyperactivity disorder self-report scale v1.1 symptom checklist to rate symptoms of attention-deficit/hyperactivity disorder in adolescents. J Child Adolesc Psychopharmacol. 2012, 22 (3): 238-244. 10.1089/cap.2011.0062.CrossRefPubMed
17.
Hines JL, King TS, Curry WJ: The adult ADHD self-report scale for screening for adult attention deficit-hyperactivity disorder (ADHD). J Am Board Fam Med. 2012, 25 (6): 847-853. 10.3122/jabfm.2012.06.120065.CrossRefPubMed
18.
Thomsen PH: Obsessive-compulsive disorder in children and adolescents. Clinical guidelines. Eur Child Adolesc Psychiatry. 1998, 7 (1): 1-11. 10.1007/s007870050038.CrossRefPubMed
19.
von Soest T, Mossige S, Stefansen K, Hjemdal O: A validation study of the resilience scale for adolescents (READ). J Psychopathol Behav. 2010, 32 (2): 215-225. 10.1007/s10862-009-9149-x.CrossRef
20.
21.
Rosenvinge JH, Perry JA, Bjorgum L, Bergersen TD, Silvera DH, Holte A: A new instrument measuring disturbed eating patterns in community populations: development and initial validation of a five-item scale (EDS-5). Eur Eat Disord Rev. 2001, 9 (2): 123-132. 10.1002/erv.371.CrossRef
22.
Garner DM, Olmsted MP, Polivy J: Eating disorder inventory. Psychopharmacol Bull. 1985, 21 (4): 1009-1010.
23.
Haugland S, Wold B: Subjective health complaints in adolescence–reliability and validity of survey methods. J Adolescence. 2001, 24 (5): 611-624. 10.1006/jado.2000.0393.CrossRef
24.
Wisting L, Froisland DH, Skrivarhaug T, Dahl-Jorgensen K, Ro O: Disturbed eating behavior and omission of insulin in adolescents receiving intensified insulin treatment: a nationwide population-based study. Diabetes Care. 2013, 36 (11): 3382-3387. 10.2337/dc13-0431.CrossRefPubMedPubMedCentral
25.
Pound N, Sturrock ND, Jeffcoate WJ: Age related changes in glycated haemoglobin in patients with insulin-dependent diabetes mellitus. Diabetic Med. 1996, 13 (6): 510-513. 10.1002/(SICI)1096-9136(199606)13:6<510::AID-DIA122>3.0.CO;2-W.CrossRefPubMed
26.
Hanas R, Adolfsson P: Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia. Pediatr Diabetes. 2006, 7 (1): 25-31. 10.1111/j.1399-543X.2006.00145.x.CrossRefPubMed
27.
Connis RT, Taylor TR, Gordon MJ, Mecklenburg RS, Liljenquist JE, Stephens JW, Baker MS: Changes in cognitive and social functioning of diabetic patients following initiation of insulin infusion therapy. Exp Aging Res. 1989, 15 (1–2): 51-60.PubMed
28.
Barnard KD, Lloyd CE, Skinner TC: Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes. Diabetic Med. 2007, 24 (6): 607-617. 10.1111/j.1464-5491.2007.02120.x.CrossRefPubMed
29.
Starkman HS, Cable G, Hala V, Hecht H, Donnelly CM: Delineation of prevalence and risk factors for early coronary artery disease by electron beam computed tomography in young adults with type 1 diabetes. Diabetes Care. 2003, 26 (2): 433-436. 10.2337/diacare.26.2.433.CrossRefPubMed
30.
Koval JJ, Pederson LL, Mills CA, McGrady GA, Carvajal SC: Models of the relationship of stress, depression, and other psychosocial factors to smoking behavior: a comparison of a cohort of students in grades 6 and 8. Prev Med. 2000, 30 (6): 463-477. 10.1006/pmed.2000.0671.CrossRefPubMed
31.
Hysing M, Pallesen S, Stormark KM, Lundervold AJ, Sivertsen B: Sleep patterns and insomnia among adolescents: a population-based study. J Sleep Res. 2013, 22 (5): 549-556. 10.1111/jsr.12055.CrossRefPubMed
32.
Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G, Group ES: Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet. 2009, 373 (9680): 2027-2033. 10.1016/S0140-6736(09)60568-7.CrossRefPubMed
33.
Metadata
Title
Mental health in adolescents with Type 1 diabetes: results from a large population-based study
Authors
Børge Sivertsen
Keith J Petrie
Ane Wilhelmsen-Langeland
Mari Hysing
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2014
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-14-83

Other articles of this Issue 1/2014

BMC Endocrine Disorders 1/2014 Go to the issue

Research article

The association between improved quality diabetes indicators, health outcomes and costs: towards constructing a “business case” for quality of diabetes care - a time series study

Research article

Fasting insulin sensitivity indices are not better than routine clinical variables at predicting insulin sensitivity among Black Africans: a clamp study in sub-Saharan Africans

Research article

Contrasting effects of preexisting hyperglycemia and higher body size on hospital mortality in critically ill patients: a prospective cohort study

Research article

Different associations between obesity and impaired fasting glucose depending on serum gamma-glutamyltransferase levels within normal range: a cross-sectional study

Research article

Partial deficiency of HIF-1α stimulates pathological cardiac changes in streptozotocin-induced diabetic mice

Case report

Central precocious puberty in a 3 year-old girl with Phenylketonuria: a rare association?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits